Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Frontiers in Oncology|October 25, 2021
Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus ChemotherapyLingling Li, Chenghui Pi, Xin Yan, et al.Nature Cancer|February 5, 2022
Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancerBaolin Liu, Xueda Hu, Kaichao Feng, et al.Therapeutics and Clinical Risk Management|September 27, 2018
Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohortDanyang Sun, Junxun Ma, Jinliang Wang, et al.American Journal of Translational Research|April 12, 2021
Efficacy and safety of crizotinib plus bevacizumab in <i>ALK/ROS-1/c-MET</i> positive non-small cell lung cancer: an open-label, single-arm, prospective observational studyZiwei Huang, Qi Xiong, Zhi Cui, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2026
Evaluation and clinical application of an accurate isotope dilution liquid chromatography-tandem mass spectrometry method for serum glycocholic acidZhonggan Jin, Yuanzhu Ou, Ming Zong, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 3, 2024
Huangqi-Danshen decoction improves heart failure by regulating pericardial adipose tissue derived extracellular vesicular miR-27a-3p to activate AMPKα2 mediated mitophagyZhaoyang Chen, Meng Zhang, Qiyao Xu, et al.Frontiers in Cell and Developmental Biology|February 24, 2022
Whole-Exome Sequencing Implicates the <i>USP34</i> rs777591A > G Intron Variant in Chronic Obstructive Pulmonary Disease in a Kashi CohortJingran Xu, Li Li, Jie Ren, et al.Therapeutic Advances in Medical Oncology|May 20, 2020
Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancerPengfei Cui, Di Huang, Zhaozhen Wu, et al.Cancer Medicine|March 22, 2022
First-line PD-1/PD-L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non-squamous non-small cell lung cancer: A Bayesian network meta-analysis of randomized controlled trialsJinzhao Zhai, Jiangyue Lu, Zhibo Zhang, et al.Plos Pathogens|January 10, 2023
CRISPR/FnCas12a-mediated efficient multiplex and iterative genome editing in bacterial plant pathogens without donor DNA templatesFang Yan, Jingwen Wang, Sujie Zhang, et al.Pageof 7